Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Dexmedetomidine for Acute Neuropathic Pain After Lower Limb Amputation
NCT07565662Completed
- Sponsor
- Universidad Juárez Autónoma de Tabasco
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in neuropathic pain and phantom limb pain (PLP) (2 arms), sponsored by Universidad Juárez Autónoma de Tabasco. Primary endpoints: Proportion Requiring Analgesic Rescue at 48 hours, Duration of Motor Block at 48 hours and 1 more. Started Sep 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
neuropathic painphantom limb pain (PLP)
Beyond the preview
Go deeper on NCT07565662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07565662.